BioSig Technologies, Inc.
BSGM
$4.11
$0.235.93%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | -- | -- | 8.33% | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | 8.33% | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | 8.33% | -- | -- |
SG&A Expenses | 302.77% | 2.60% | -78.21% | -1.85% | -46.04% |
Depreciation & Amortization | 1,030.61% | -73.08% | -67.74% | -66.30% | -46.74% |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 283.88% | -6.69% | -80.64% | -27.20% | -51.37% |
Operating Income | -284.83% | 6.28% | 80.82% | 27.18% | 51.49% |
Income Before Tax | -420.79% | 18.01% | 82.07% | 52.74% | 64.86% |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -420.79% | 18.01% | 82.07% | 52.74% | 64.86% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | 0.00% | -192.31% | -100.00% | -- | -110.81% |
Net Income | -420.36% | 17.34% | 81.83% | 58.09% | 64.71% |
EBIT | -284.83% | 6.28% | 80.82% | 27.18% | 51.49% |
EBITDA | -277.82% | 4.60% | 81.02% | 26.27% | 51.53% |
EPS Basic | -142.43% | 62.27% | 90.64% | 80.25% | 80.79% |
Normalized Basic EPS | -79.00% | 54.47% | 89.88% | 72.01% | 73.93% |
EPS Diluted | -142.43% | 62.27% | 90.64% | 80.25% | 80.79% |
Normalized Diluted EPS | -79.00% | 54.47% | 89.88% | 72.01% | 73.93% |
Average Basic Shares Outstanding | 114.51% | 110.91% | 97.59% | 114.95% | 83.78% |
Average Diluted Shares Outstanding | 114.51% | 110.91% | 97.59% | 114.95% | 83.78% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |